胸腹主动脉瘤直径对开窗/分支支架修复结局的影响
该多中心回顾性研究分析了247例胸腹主动脉瘤患者,以术前瘤体直径≥80 mm为界值,比较开窗/分支支架修复的结局。结果发现直径≥80 mm未显著影响技术成功率和早期死亡率,但脊髓损伤发生率更高(17% vs 7%,P=0.03),且为再干预和目标内脏血管不稳定的独立危险因素。
要点
- 术前瘤体直径≥80 mm的患者脊髓损伤发生率显著高于<80 mm者(17% vs 7%,P=0.03)。
- 直径≥80 mm是再干预的独立危险因素(HR 1.9,95%CI 1.1-3.6,P=0.04)。
- 直径≥80 mm是目标内脏血管不稳定的独立危险因素(HR 3.1,95%CI 1.3-5.1,P=0.04)。
核心结论
- 术前胸腹主动脉瘤直径>80 mm对早期技术成功和临床结局无直接影响。
- 直径≥80 mm是随访期再干预和目标内脏血管不稳定的独立危险因素,但竞争风险分析后无统计学意义。
研究设计与样本
- 回顾性分析2个欧洲中心2011-2021年接受开窗/分支支架胸腹主动脉修复的247例胸腹主动脉瘤患者。
- 以瘤体直径第三四分位数80 mm为界值分组比较,中位随访13个月(IQR 2-37)。
主要发现
- 技术成功率93%(<80 mm组91% vs ≥80 mm组94%,P=0.47)。
- 3年生存率65%,免于再干预率62%;再干预45例(18%)。
关键数值与推荐
- 定制分支支架160例(65%),现货分支支架87例(35%)。
- 多因素分析未将术前直径≥80 mm列为主要终点的显著危险因素。
- 再干预独立危险因素:术前直径≥80 mm(HR 1.9,95%CI 1.1-3.6,P=0.04)。
- 目标内脏血管不稳定独立危险因素:术前直径≥80 mm(HR 3.1,95%CI 1.3-5.1,P=0.04)。
- 竞争风险分析后,术前直径对随访结果无显著影响。
临床怎么用
- 对于胸腹主动脉瘤直径≥80 mm的患者,应加强随访监测再干预和目标内脏血管不稳定。
- 术前直径≥80 mm不影响早期技术成功和死亡率,但需警惕脊髓损伤风险升高。
局限性
- 回顾性研究设计,仅纳入2个欧洲中心,可能存在选择偏倚。
- 中位随访时间较短(13个月),长期结局需进一步验证。
- 竞争风险分析后直径≥80 mm对随访结果无显著影响,需谨慎解读独立危险因素。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Aim of the study was to analyse the impact of preoperative thoracoabdominal aneurysm diameter on the outcomes of fenestrated/branched endografting. METHODS: Patients who underwent endovascular thoracoabdominal repair at 2 European centres (2011-2021) were analysed. Median diameter was calculated; the third quartile was considered a cut-off. Outcomes were compared in 2 groups based on the diameter value. Primary endpoints were technical success, spinal cord ischaemia and 30-day/in-hospital mortality. Survival, freedom from reintervention and target visceral vessels instability were follow-up outcomes. RESULTS: Out of 247 thoracoabdominal aortic aneurysms, the median diameter was 65 mm, first quartile was 57 mm; third quartile was 80 mm, set as cut-off value. Fifty-nine (24%) patients had diameter ≥80 mm. Custom-made and off-the-shelf branched endograft were used in 160 (65%) and 87 (35%), respectively. Technical success was 93% (<80 mm: 91% vs ≥80 mm: 94%; P = 0.47). Twenty-three (9%) patients had spinal injury (<80 mm: 7% vs ≥80mm: 17%; P = 0.03). Twenty-two (9%) patients died within 30-day/in-hospital (<80 mm: 7% vs ≥80 mm: 15%; P = 0.06). Multivariate analysis did not report preoperative diameter ≥80 mm as significant risk factor for primary endpoints. The median follow-up was 13 (interquartile range: 2-37) months and at 3-year survival and freedom from reintervention rates were 65% and 62%, respectively. After univariate and multivariate analyses, preoperative diameter ≥80 mm was considered an independent risk factor for reinterventions [hazard ratio (HR): 1.9; 95% confidence interval (CI) 1.1-3.6; P = 0.04], and for target visceral vessels instability (HR: 3.1; 95% CI: 1.3-5.1; P = 0.04), occurred in 45 (18%) cases. However, after competing risk methods, preoperative diameter did not show significance for follow-up results. CONCLUSIONS: A preoperative thoracoabdominal aortic aneurysm diameter >80 mm has not had a direct impact on early technical and clinical outcomes. A diameter≥80 mm is considered risk factor for reinterventions and target vessels instability is considered separately during follow-up.
引用
- Gallitto E, Tsilimparis N, Spath P, et al. The impact of large aneurysm diameter on the outcomes of thoracoabdominal aneurysm repair by fenestrated and branched endografts. Eur J Cardiothorac Surg. 2024. PMID: 39447039. doi:10.1093/ejcts/ezae387
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。